Although Somaratne et al. also investigated the value of serum NT-proBNP to screen for LVH in T2DM, the results showed that serum NT-proBNP was unsuitable for a screening tool because of the influence of obesity or other metabolic risk factors [32]. The gene discussed is NPPB; the disease is obesity due to melanocortin 4 receptor deficiency.